Skip Navigation


Biostatistics Advance Access originally published online on September 15, 2006
Biostatistics 2007 8(3):526-545; doi:10.1093/biostatistics/kxl027
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
8/3/526    most recent
kxl027v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Egleston, B. L.
Right arrow Articles by West, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egleston, B. L.
Right arrow Articles by West, S. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Causal inference for non-mortality outcomes in the presence of death

Brian L. Egleston*

Biostatistics Facility, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA Brian.Egleston{at}fccc.edu

Daniel O. Scharfstein

Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205, USA

Ellen E. Freeman and Sheila K. West

Department of Ophthalmology, Johns Hopkins University, Baltimore, MD 21205, USA

* To whom correspondence should be addressed.


    SUMMARY
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
Evaluation of the causal effect of a baseline exposure on a morbidity outcome at a fixed time point is often complicated when study participants die before morbidity outcomes are measured. In this setting, the causal effect is only well defined for the principal stratum of subjects who would live regardless of the exposure. Motivated by gerontologic researchers interested in understanding the causal effect of vision loss on emotional distress in a population with a high mortality rate, we investigate the effect among those who would live both with and without vision loss. Since this subpopulation is not readily identifiable from the data and vision loss is not randomized, we introduce a set of scientifically driven assumptions to identify the causal effect. Since these assumptions are not empirically verifiable, we embed our methodology within a sensitivity analysis framework. We apply our method using the first three rounds of survey data from the Salisbury Eye Evaluation, a population-based cohort study of older adults. We also present a simulation study that validates our method.

Keywords: Causal inference; Competing risk; Emotional distress; Sensitivity analysis; Vision loss


    1. INTRODUCTION
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
In studies of older individuals, researchers are often interested in evaluating the effect of exposure on morbidity as well as mortality outcomes. When analyzing morbidity outcomes, the competing risk of death must be taken into account. Any meaningful analysis must recognize that a participant's morbidity outcome at a specified point in time is not defined if he/she died before that time.

An analysis which compares morbidity outcomes for study participants who are observed to live in exposed and nonexposed groups is problematic, since the survivors in the exposed group are not necessarily exchangeable with the survivors in the nonexposed group. Further, participants who would live when they have the exposure might not live when they do not have the exposure, in which case even a poor morbidity outcome with exposure might be better than the mortality outcome without exposure.

There are numerous examples in the gerontologic literature in which researchers are interested in comparing non-mortality outcomes across treatment or exposure groups in panel surveys but find inferences complicated by the death of study participants between panels. Common approaches to this problem are to examine outcomes across observed survivors, considering those who died to be cases lost to follow-up, with occasional discussions about how inferences are affected by the fact that those who died differed from those who survived (Avlund and others, 2004Go; Gilley and others, 2004Go; van Hooren and others, 2005Go; Chen and Wilmoth, 2004Go; Steunenberg and others, 2005Go; Boerner and others, 2005Go). An alternative method, which changes the inferential objective, is to create a composite end point including death and morbidity (Avlund and others, 2004Go). The use of traditional survival analytic techniques that allows for the modeling of death as a competing risk are not necessarily applicable to these studies, since the time of death is often observed but the time of an incident morbidity outcome is not.

An additional limitation of traditional techniques is that they are generally not causally interpretable. When an exposure's effect on a non-mortality outcome is examined among the observed survivors at a fixed time point, it is not possible to disentangle the effect due to the exposure's impact on the non-mortality outcome from the exposure's impact on mortality among those at high risk of having the non-mortality outcome. If the propensity to have the non-mortality outcome is linked to the propensity to die, then it is possible that a harmful exposure will kill off a vulnerable population, leaving only healthy survivors. At the end of the study, the effect of the exposure might appear beneficial on the non-mortality outcome, when the effect is an artifact of the exposure's impact on mortality. The crux of the problem is that the non-mortality outcome is not defined if someone dies. It is not meaningful to compare a person's functional outcomes under two exposure categories if the person dies when they have one exposure but not the other. This limits the interpretability of effect estimates among study survivors. The growth of gerontologic analyses based on longitudinal panel surveys (Ferraro and Kelley-Moore, 2003Go) only heightens the need for interpretable estimands and inferential techniques for non-mortality outcomes.

Using the potential outcomes formalization of causal inference, developed by Neyman (1923)Go, Rubin (1974)Go, and Holland (1986)Go, Frangakis and Rubin (2002)Go introduced a meaningful causal estimand: The causal effect of exposure on the morbidity outcome among participants who would live regardless of their exposure. Rubin (2000)Go and Hayden and others (2005)Go referred to this estimand as the survivors average causal effect (SACE). Robins (1995)Go proposed a conceptually similar estimand in the context of semi-competing risks, while Robins and Greenland (2000)Go described an estimand identical to SACE. SACE falls into a general class of estimands, called principal stratum causal effects, where a principal stratum is defined by potential outcomes (Frangakis and Rubin, 2002Go). In this context, the principal stratum is the set of participants who would survive regardless of their exposure.

The identification of SACE and other principal stratum causal effects usually rely on untestable assumptions. There has been a flurry of recent methodological work regarding inference about SACE and SACE-like estimands in the context of randomized studies. Table 1 compares and contrasts some of the key aspects of these works. Gilbert and others (2003)Go and Hudgens and others (2003)Go discussed inference about the causal effect of exposure among the participants who would become HIV infected regardless of whether they received a vaccine or placebo. While Hudgens and others (2003)Go focused on conditions for testing the null hypothesis of no causal effect, Gilbert and others (2003)Go discussed estimation under a class of identifiability conditions, indexed by an interpretable sensitivity analysis parameter. These authors assumed monotonicity, which states that "no subject would be infected if randomized to vaccine, but would be uninfected if randomized to placebo." Zhang and Rubin (2003)Go discuss population bounds for SACE under no assumptions and under monotonicity, which in their context means that if a subject lives when given a placebo, he/she would also live when given a treatment. Hayden and others (2005)Go developed a likelihood-based sensitivity analysis procedure for estimating SACE. Their methodology incorporates covariates, does not impose monotonicity, and assumes a cumulative proportional odds model restriction. Their model admits identification of a joint distribution of the potential outcomes. They also address how their method can be adjusted to handle missing outcomes and, for this situation, propose using the bootstrap to obtain standard errors.


View this table:
[in this window]
[in a new window]

 
Table 1. Comparison of sensitivity analysis methods used for drawing inference about SACE or SACE-like estimands

 
In this paper, we propose a sensitivity analysis procedure for drawing inference about SACE in the context of observational studies with missing outcomes among observed survivors. Our sensitivity analysis parameterization is similar to that of Gilbert and others (2003)Go. While we impose monotonicity, our modeling approach does not yield identification of the entire joint distribution of potential outcomes, just features of the joint distribution which are necessary for estimating SACE. In contrast, Hayden and others (2005)Go seek identification of the entire joint distribution of the counterfactuals and as a consequence require more assumptions (even if monotonicity were imposed). The advantage of their approach is that it admits identification of other functionals of the joint distribution of the potential outcomes, although these functionals are not discussed in either the paper of Hayden and others or this paper.

The paper is organized as follows. In Section 2, we introduce our motivating observational study, the Salisbury Eye Evaluation (SEE), in which gerontologic researchers are interested in the effect of vision loss on emotional distress. In Section 3, we introduce the data structure and notation for the SEE study. In Section 4, we mathematically define SACE and present our two alternative sets of identifiability assumptions, indexed by sensitivity analysis parameters. We also discuss additional testable models for our estimation procedure. In Section 5, we introduce our estimators and derive their large sample properties. In Section 6, we apply SACE to the SEE study. We finish with a discussion in Section 7.

An R program to implement our method is available from the authors.


    2. THE SEE
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
Visual impairment is a common problem in older adults, as 15–20% of adults in their 80s are afflicted (Munoz and others, 2000Go). Loss of vision can result in increased dependence on others, less social interaction, and increased disability. Therefore, these individuals may be at an increased risk of emotional distress, which may lead to further deterioration in health.

Some studies have found an association between visual impairment and the emotional distress symptom of depression, but to our knowledge almost all have been cross-sectional (Rovner and others, 1996Go; Scott and others, 2001Go; Rovner and Ganguli, 1998Go; Jorm and others, 1995Go; Carabellese and others, 1993Go). One problem with investigating this relationship longitudinally in older individuals is that death is a competing risk that is associated with both visual impairment and depression (McCarty and others, 2001Go; Klein and others, 1995Go; Thompson and others, 1989Go; Blazer and others, 2001Go; Schulz and others, 2000Go; Stern and others, 2001Go; Black and Markides, 1999Go).

To investigate if incident vision loss increases the risk of emotional problems, we used data from the SEE project, a population-based cohort study of older adults (West and others, 1997Go). In this study, visual acuity was assessed using the Early Treatment Diabetic Retinopathy Study eye chart, and emotional distress symptoms were assessed using the General Health Questionnaire (GHQ) which rates emotional distress on a scale of 0 to 28 (Goldberg and Hillier, 1979Go). Incident vision loss was defined as a loss of two or more lines on an eye chart of the best visual acuity possible with glasses at the second round, 2 years after the baseline round. Those with severe baseline visual impairment who were not able to have at least two lines of vision loss were excluded from the study. The outcome of interest was incident worsened emotional distress at the third round, which occurred 4 years later. Worsened emotional distress is defined by a worsening of four or more points in the total GHQ score. The total GHQ score has been found to have strong correlation with clinically relevant depression (Goldberg and Hillier, 1979Go).

Table 2 presents summary statistics of our sample. In the second and fourth columns of Table 2, we present summary statistics for each of these baseline characteristics, stratified by vision loss status. The third and fifth columns present summary statistics for the subgroup who survived past the third round, stratified by vision loss status. As shown in the table, a significant proportion of individuals died before emotional distress could be assessed at the last round (24.7% of those with vision loss versus 15.4% of those without vision loss). These high mortality rates underline the importance of accounting for death as a competing risk in these data.


View this table:
[in this window]
[in a new window]

 
Table 2. Summary statistics for covariate and outcome data, stratified by vision loss status

 
In addition to death, loss to follow-up and worsening emotional distress symptom rates were higher for those with vision loss as compared to those without vision loss in our study. Within each vision loss stratum, the baseline characteristics for the entire stratum versus the subgroup who survived to round 3 and were not lost to follow-up were comparable. However, there were differences between vision loss strata. Those with vision loss tended to (a) be older, (b) have more comorbidities, (c) be more likely to be male, (d) be more likely to be nonwhite, (e) be more likely to have diabetes, (f) have lower body mass index (BMI), which is often clinically worse in older persons compared with a higher BMI, (g) smoke more, and (h) be better educated. Thus, those with vision loss tended to be less healthy. Not all these differences were statistically significant, however, as shown in Table 2. We designed our proposed estimator of SACE to correct for bias that could result from such loss to follow-up and baseline differences between those with and without vision loss in the data set.

For the analysis in Section 6, our reference population was drawn from the set of subjects who (a) survived through round 2; (b) had measures of visual acuity and emotional distress at round 2; (c) had information on covariates such as age, gender, race, diabetes, hypertension, number of comorbidities, BMI, smoking status, and education at round 2; and (d) had information on mortality through round 3. Missing measures of emotional distress among survivors at round 3 were due to loss to follow-up.


    3. DATA STRUCTURE AND NOTATION
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
In the potential outcomes framework, it is assumed that, associated with each individual, there are outcomes under two states of nature: one when a person has vision loss and the other when the same person does not have vision loss. Only one of these states of nature is actually observed. Our data structure reflects this assumption.

Let X be the vector of covariates and let Z be an indicator of vision loss (1 if vision loss, 0 otherwise). Let D(1) indicate a person's mortality outcome when they have vision loss (1 if death, 0 otherwise); similarly, define D(0) to be the same person's mortality outcome when they do not have vision loss. Let Y(1) be the emotional distress outcome when a person has vision loss and Y(0) be the outcome when the same person does not have vision loss (1 if worsened emotional distress symptoms, 0 otherwise). Y(0) and Y(1) are only defined if a person survives with the respective vision loss.

Let D = D(Z) and Y = Y(Z) be the observed mortality and worsened distress outcomes. Let R be an indicator of whether a survivor is interviewed at the final survey round in our study (1 if not lost to follow-up, 0 otherwise). We assume that we observed n i.i.d. copies of the observed data,

Formula

Figure 1 is a graphical representation of the relationship between the observed and the potential data.


Figure 1
View larger version (11K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1. Relation of observed to potential data.1

 
The goal is to use the observed data to draw inference about SACE, the odds ratio (OR) of worsening emotional distress in the group that would survive either with or without vision loss. Specifically, we define

Formula (3.1)

Note, however, that SACE could also have been defined as, say, a relative risk (RR) or risk difference.

In identifying SACE, we will find it useful to define the following quantities which are identifiable from the distribution of the observed data for z = 0,1:

Formula


    4. IDENTIFICATION OF SACE
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
In this section, we present assumptions to identify SACE from the observed data distribution. Before turning to these assumptions, we introduce an example, which will be used to demonstrate (a) the difficulty of drawing valid causal inferences from the observed data and (b) how the assumptions are used to identify SACE.

4.1 Illustrative example

Table 3 displays the potential outcomes and a binary covariate (X) for a hypothetical population of 4500 individuals. Within each level of X, the individuals are spread equally across the three principal strata: those who live regardless of their vision loss (S1) where {D(0) = 0,D(1) = 0}, those who would die if they had vision loss but survive if they did not (S2) where {D(0) = 0,D(1) = 1}, and those who would die both with and without vision loss (S3) where {D(0) = 1,D(1) = 1}. No individuals are in the stratum who would die without vision loss but survive with vision loss (S4) where {D(0) = 1,D(1) = 0}. Among the 1000 who would always be alive with X = 0, there is no emotional distress whatever be their vision loss. Among the 500 who would always be alive with X = 1, there is emotional distress whatever be their vision loss. For the individuals who would die only if they have vision loss, we see that their potential emotional distress outcomes when they have vision loss are not defined and two-thirds would have emotional distress when they do not have vision loss. For the individuals who die regardless of their state of vision, their potential emotional distress outcomes are undefined. The causal effects among these latter strata are undefined. Causal inferences are only meaningful in the stratum of those who would always remain alive. In this stratum, the causal OR of emotional distress for vision loss versus no vision loss is 1 (i.e. no causal effect).


View this table:
[in this window]
[in a new window]

 
Table 3. Potential outcome and covariate data for a hypothetical population

 
Only a coarse version of Table 3 is observable. In Table 4, we present the observed data. As in Table 3, there are 3000 subjects with X = 0 and 1500 with X = 1. Within levels of X, subjects are spread equally across the vision status stratum. Regardless of X, subjects who have vision loss have an odds of dying of two and subjects without vision loss have an odds of dying of 0.5. Among the survivors, half of the subjects have mental health assessments. For subjects who survive, and have mental health assessments, the OR of emotional distress between subjects with and without vision loss is 0.5. An incorrect interpretation of this analysis would suggest that, overall, vision loss is protective against emotional distress and the protection holds only for the subgroup with X = 0. Why do we see this result? For subjects who survive and have mental health assessments, the subgroup with no vision loss (see lines 1–4 of Table 4) is a mixture of those who would always remain alive and those who would die only if they had vision loss (half S1 and half S2), while the subgroup with vision loss (see lines 7–8 of Table 4) consists of subjects who would always remain alive (S1). Thus, these subgroups are not comparable with regard to their principal strata. Since the rate of emotional distress in S2 is higher than that in S1 as illustrated in Table 3, we see why vision loss "looks" protective.


View this table:
[in this window]
[in a new window]

 
Table 4. Observed data for a hypothetical population

 
4.2 Assumptions

We introduce the following non-identifiable assumptions in order to identify SACE from the distribution of the observed data. To identify SACE, we can separately identify (a) P[Y(1) = 1|S1] and (b) P[Y(0) = 1|S1]. We make the common Stable Unit Treatment Value Assumption (Rubin, 1980Go) which states that an individual's potential outcomes are unrelated to both the vision loss status of other study participants and the mechanism by which the individual lost their vision. Below, we list the assumptions specific to our estimator and label them using terminology common to the field of causal inference where appropriate (Rosenbaum and Rubin, 1983).

Assumption 1. D(0) ≤ D(1) (Monotonicity).

Assumption 1 states that the development of vision loss does not improve the mortality outcome of an individual. This assumption is similar to assumptions made by Gilbert and others (2003)Go and Zhang and Rubin (2003)Go. One might challenge this assumption if vision loss reduces mortality by restricting activities (e.g. walking) that might cause death in older adults (e.g. falls). In our analysis, we believe that such a protective effect of vision loss is at most negligible since visual impairment and vision loss have been shown to have a strong relationship with mortality (see Freeman and others, 2005Go, for a review). For the illustrative example, this assumption implies that no subjects are in the principal stratum of subjects who die only without vision loss (S4). In column 9 of Table 4, the stratum S4 is removed. Thus, for subjects in lines 7–12, we know their principal stratum.

Assumption 2. Z{perp}P|X (Strong ignorability).

Assumption 2 states that the development of vision loss is unrelated to the potential outcomes given the covariates. Rosenbaum and Rubin (1983) referred to this assumption as "strong ignorability of treatment assignment." Since vision loss is not randomized, we assume that within strata of confounders there are no unmeasured differences between those who lose vision and those who do not. One implication of this assumption is that P[D(z) = 0|X] = gz(X) and P[Y(z) = 1|D(z) = 0,X] = P[Y = 1|D = 0,Z = z,X]. Assumptions 1 and 2 imply that E[g0(X)] ≥ E[g1(X)].

In the illustration, where X is a one-dimensional binary variable, g0(0) = 2/3, g0(1) = 2/3, g1(0) = 1/3, and g1(1) = 1/3.

Assumption 3. R{perp}Y|D = 0,Z,X.

This assumption states that, for survivors, missingness of the morbidity outcome is independent of the value of the outcome within levels of exposure and covariates. This is related to the "missing at random" assumption of Rubin (1976)Go. It allows one to identify the probability of emotional distress in the group of survivors with missing emotional distress outcomes, within levels of Z and X. Together with Assumption 2, we have that P[Y(z) = 1|D(z) = 0,X] = hz(X).

In our illustrative example, h0(0) = 0.5, h0(1) = 0.5, h1(0) = 0, and h1(1) = 1. Further, we can compute some key quantities that will be needed in the identification of SACE. In particular, Formula . Here, we show how these assumptions can be used to identify SACE.

Under Assumptions 1–3,

Formula (4.1)

To see this, note that

Formula

The first equality follows from Assumption 1. The second equality follows from the properties of conditional and unconditional expectations. The third equality follows from Assumptions 2 and 3 and from the definition of h1(X) and g1(X).

Application of this formula to our illustration yields Formula

Assumption 4 contains two sub-assumptions, each of which can be used in the identification of P[Y(0) = 1|S1]. These are motivated by the following key identity:

Formula (4.2)

Such mixing equations are commonly used to identify causal estimands using observed data (Gilbert and others, 2003Go; Zhang and Rubin, 2003Go). Under Assumptions 1–3, the left-hand side of (4.2) is identifiable since

Formula (4.3)

and the "mixing" probability P[D(1) = 0|D(0) = 0] is identifiable since

Formula (4.4)

These equalities can be proved using similar manipulations as in the proof of (4.1).

By specifying how P[Y(0) = 1|S2] relates to P[Y(0) = 1|S1] in (4.2), we can then solve (4.2) for P[Y(0) = 1|S1].

Assumption 4a.


Formula (4.5)

where {tau}RR is a specified constant, interpreted as the RR of worsening emotional distress without vision loss when comparing the group of individuals that would survive without vision loss but die with vision loss (S2) to the group of individuals who would live regardless of vision loss (S1). The constant {tau}RR is non-identifiable from the observed data because we do not know to which principal stratum individuals who are observed in our study to survive without vision loss belong. To identify the principal strata directly, we would need to observe the counterfactual mortality outcomes that individuals would have had if they had vision loss for those in the study who did not actually develop vision loss. Since we do not observe those counterfactual outcomes, we need this assumption. Our final inferences about SACE will be displayed in the form of a sensitivity analysis. That is, SACE will be estimated over a range of {tau}RR considered plausible by subject matter experts.

Gilbert and others (2003)Go posed a similar assumption, while Hayden and others (2005)Go made one based on covariates. From a sensitivity analysis perspective, this modeling decision is critical. If we did condition on covariates and the covariates were high-dimensional, subject matter experts might find it unreasonable to assume a constant RR across all levels of X. If {tau}RR were chosen to depend on X, then the sensitivity analysis would become too complicated to display. Under the conceptualization of the problem of Hayden and others (2005)Go, we would need many more {tau}-like parameters, even with our monotonicity assumption, to identify our estimand, particularly when dealing with continuous outcomes. Hayden and others (2005)Go reduce the dimension of the sensitivity parameters in their work by assuming proportionality across all levels of X.

A possible drawback to our approach is that there may be no immediate "anchoring point" of {tau}RR which is considered plausible by scientific experts. For example, {tau}RR = 1, which implies Y(0) is independent of D(1) given D(0) = 0, may be considered implausible. Instead, experts might be more comfortable anchoring the sensitivity analysis at an assumption that states that Y(0) is independent of D(1) given D(0) = 0 and X. This assumption is part of what Hayden and others (2005)Go call "explainable nonrandom survival." We refer to it as "counterfactual conditional independence" (CCI) to emphasize that it is a conditional independence assumption involving two variables that we could never observe on the same person (Y(0) is only observed if a person does not have vision loss, while D(1) is only observed if a person does have vision loss). In our framework, {tau}RR = 1 is simply "counterfactual independence," where we do not condition on any covariates to obtain independence. One can identify the unconditional {tau}RR which corresponds to CCI. Then, an expert can use this value of {tau}RR as their anchoring point in the sensitivity analysis. While anchoring might be a useful guide for scientific experts who desire a unique point estimate around which to base the sensitivity analysis, it is not essential. A sensitivity analysis can be performed over any range of {tau}RR that is plausible, and this range of estimates can be reported. If the anchoring point is not within the sensitivity range, then researchers will have to reconsider whether the anchoring point assumption is scientifically meaningful or whether the range of {tau}RR needs to be expanded.

Under Assumptions 1–3 and 4a,

Formula (4.6)

provided

Formula (4.7)

When E[g0(X)] > E[g1(X)], P[Y(0) = 1|S1] decreases to 0 as {tau}RR->{infty}. When E[g0(X)] = E[g1(X)], P[Y(0) = 1|S1] = E[h0(X)g0(X)]/E[g1(X)], for all {tau}RR.

Equation (4.6) is derived by plugging (4.3) and (4.4) into (4.2), substituting {tau}RRP[Y(0) = 1|S1] for P[Y(0) = 1|S2], and solving for the unknown of interest, P[Y(0) = 1|S1]. The constraint in (4.7) is imposed to guarantee that the solution is a proper probability.

Using (4.1) and (4.6), we can compute SACE as a function of {tau}RR. We denote this function as SACE{tau}RR(·). This function, defined for {tau}RR satisfying constraint (4.7), can be shown to be increasing in {tau}RR when E[g0(X)] > E[g1(X)].

In our illustration, the unknowable value of {tau}RR is 2. Using this value, we see that Formula . The bound in (4.7) equals Formula . Above, we saw that P[Y(1) = 1|S1] = 1/3. So, SACE{tau}RR(2) = 1, indicating correctly that there is no causal effect of vision loss on emotional distress for those who would always survive regardless of vision loss. Figure 2 displays the function SACE{tau}RR(·) for {tau}RR ≥ 0 for our illustration. It is interesting to note that the unconditional {tau}RR that is obtained under CCI is 1, yielding incorrect inference.


Figure 2
View larger version (8K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2. SACE for illustrative data under RR & OR parameterizations of {tau}.

 
Instead of modeling the relationship between P[Y(0) = 1|S2] and P[Y(0) = 1|S1] via RR, we can also model the OR.

Assumption 4b.


Formula (4.8)

where {tau}OR is a specified constant, interpreted in the same manner as {tau}OR but on the OR scale.

Under Assumptions 1–3 and 4b,

Formula

when {tau}OR = 1. When {tau}OR¬1,

Formula (4.9)

where

Formula

As {tau}OR->{infty}, P[Y(0) = 1|S1] converges to

Formula

This result is derived by plugging (4.3) and (4.4) into (4.2), substituting

Formula

for P[Y(0) = 1|S2], and solving for the unknown of interest, P[Y(0) = 1|S1]. The solution is trivial when {tau}OR = 1. When {tau}OR¬1, the solution is found by solving a quadratic equation, of which only the above solution is a proper probability. The solution is a decreasing function of {tau}OR. There are no constraints on {tau}OR. Using (4.1) and (4.9), we can compute SACE as a function of {tau}OR. We denote this function as SACE{tau}OR(·). This function can be shown to be increasing in {tau}OR.

In the illustration, the true {tau}OR = 4. In (4.9), Formula and SACE{tau}OR(4) = 1. This correctly indicates that there is no causal effect of vision loss on emotional distress for those who would always survive. Figure 2 displays the function SACE{tau}OR(·) for all {tau}OR ≥ 0. As above, the unconditional {tau}OR that is obtained under CCI is also 1, leading to invalid inference.

Study specific assumption. {tau}RR ≥ 1 and {tau}OR ≥ 1.

This assumption encodes a plausible belief about the direction of the RR of emotional distress in a world in which no one has vision loss when comparing two principal strata. The direction implies that the risk in such a world of no vision loss would be larger among the group who would live without vision loss only (but would die if they had vision loss) than in the group who would live both with and without vision loss. This assumption seems reasonable in that the group that would die if they had vision loss is likely less healthy and more frail than the group that would survive if they had vision loss. However, those who see this belief as arbitrary could estimate effects over any range of appropriate sensitivity values. In our example, the true values of {tau}RR and {tau}OR are 2 and 4, respectively. In other studies, researchers might use scientific information to obtain different bounds on the sensitivity parameter.


    4.3 Models for gz(X) and hz(X)
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
In the identification formulas above, we see that P[Y(z) = 1|S1] can be expressed as a function of {nu}Formula = P[D(0) = 0] = E[g0(X)], {nu}Formula = P[D(1) = 0] = E[g1(X)], {xi}Formula = P[D(0) = 0,Y(0) = 1] = E[h0(X)g0(X)], and {xi}Formula = P[D(1) = 0,Y(1) = 1] = E[h1(X)g1(X)]. This implies that SACE is a function of these quantities (see (4.6) and (4.9)). Thus, we need to compute gz(X) and hz(X). When X is high-dimensional, it is not possible to estimate these quantities non-parametrically, due to the curse of dimensionality. To achieve an estimator of SACE which converges at Formula rates, we will need to impose some lower-dimensional restrictions on these quantities. Specifically, we assume that, for z = 0,1,

Formula (4.10)


Formula (4.11)

where gFormula(X;{alpha}z) and hFormula(X;{alpha}z) are specified functions of X and parameter vectors {alpha}z (jzx1) and ßz (kzx1), respectively; {alpha}Formula and ßFormula denote the true parameter values. Under these models, we then see that

Formula

where expit{x} = exp{x}/(1 + exp{x}). Note that {nu}Formula and {xi}Formula depend on {alpha}Formula and ßFormula as well as the distribution of X.


    5. ESTIMATION AND LARGE SAMPLE THEORY
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
Here we present the methods for estimating SACE. First, define

Formula

We assume that {psi}*isin{Psi}, where

Formula

Under this notation and assumption, {tau}Formula in (4.7) is equal to Formula .

5.1 {psi}*

To estimate {psi}*, we first estimate {alpha}Formula and ßFormula via maximum likelihood using logistic regressions that include all the confounding covariates. We denote these estimators by Formulaz and Formulaz. Then, it is natural to estimate {nu}Formula and {xi}Formula by

Formula

where, for a random variable U on which we have n i.i.d. observations, Formula . In words, we are using the results from the logistic regressions to estimate for each individual the probability of survival and the conditional probability of worsened emotional distress given survival for both potential vision loss categories. We then average the estimated survival probabilities within each vision loss category to obtain marginal estimated probabilities, Formula0 and Formula1. Similarly, we average the product of the estimated probabilities of survival and the estimated probabilities of worsened emotional distress given survival within each vision loss category to get estimated marginal probabilities of surviving with worsened emotional distress, Formula0 and Formula1. These estimators form the estimates needed for {psi}* which we call Formula. Obtaining estimators in this way is equivalent to solving the following unbiased equation:

Formula

where

Formula

It is easy to show that E[U(O;{psi}*)] = 0. By the theory of M-estimation (Huber, 1964), it can be shown that, for {psi}*isin{Psi},

Formula

where

Formula

The covariance matrix {Sigma}* can be estimated by

Formula

5.2 SACE(·)

Under Assumptions 1–3, 4a, (4.10) and (4.11), SACE becomes,

Formula

For fixed {tau}RR satisfying {tau}RR > 1, this function is continuously differentiable for all {psi}*isin{Psi}. We estimate SACE{tau}RR({tau}RR) by SACE{tau}RR ({tau}RR, Formula). The large sample theory for this estimator can be found by employing the delta method. Specifically,

Formula

where

Formula

and {triangledown}SACE{tau}RR({tau}RR,{psi}) is the gradient of SACE{tau}RR({tau}RR,{psi}) with respect to {psi}. The variance–covariance matrix {Gamma}{tau}RR({tau}RR;{psi}*) is consistently estimated by {Gamma}{tau}RR ({tau}RR; Formula).

Under Assumptions 1–3, 4b, (4.10) and (4.11), SACE becomes

Formula

where

Formula

For fixed {tau}OR satisfying {tau}OR > 1, this function is continuously differentiable for all {psi}*isin{Psi}. We estimate SACE{tau}OR({tau}OR) by SACE{tau}OR({tau}OR, Formula). The large sample theory for this estimator can be found by employing the delta method as above. Specifically,

Formula

where

Formula

and {triangledown}SACE{tau}OR({tau}OR,{psi}) is the gradient of SACE{tau}OR({tau}OR,{psi}) with respect to {psi}. The variance–covariance matrix {Gamma}{tau}OR({tau}OR;{psi}*) is consistently estimated by {Gamma}{tau}OR ({tau}OR; Formula).

To guarantee that Wald-type confidence intervals for SACE are nonnegative, we recommend that the confidence interval first be computed for log(SACE) and then exponentiated. The asymptotic distribution of log(SACE) is found by the delta method.

We conducted a simulation study to evaluate the finite sample behavior of our estimation procedure for SACE, the results of which are presented in the supplementary material available at Biostatistics online (http://www.biostatistics.oxfordjournals.org). Overall, the results suggest that the inferences made using our asymptotic theory are generally valid. Misspecifying the correct sensitivity parameter, {tau}RR or {tau}OR, however, can lead to substantial bias. This underlines the importance of a sensitivity analysis approach to presenting results when the true {tau}RR or {tau}OR is unknown.


    6. DATA ANALYSIS
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
We used data from the SEE study to demonstrate our method. Of the 2520 subjects in the study, 32 were not at risk of losing two lines of vision because of severe visual impairment, 137 died before their second round interview, and 191 had missing information or were lost to follow-up at or before the second round. These subjects were excluded. Of the remaining 2160 subjects, 162 had vision loss diagnosed at the second interview. In this data set, the covariates, X, are age, gender, race, diabetes, hypertension, number of comorbidities, BMI, smoking status, and education.

We first used a naive logistic regression to investigate the effect of vision loss on emotional distress among the group observed to survive conditional on X. After adjusting for covariates, subjects with vision loss have 1.26 times the odds of worsening emotional distress as compared to those without vision loss (95% CI: [0.65, 2.46]). The increase in the odds of distress is of modest clinical relevance and is not statistically different than 1 at the 0.05 Type-I error level.

Next, we employed our sensitivity analysis approach to estimate SACE. We fit models (4.10) and (4.11), in which the functions gFormula(X;{alpha}z) and hFormula(X;ßz) are assumed to be linear in age, sex, race, diabetic and hypertensive status, number of comorbidities, lowest quartile BMI, having ever smoked, and having a high school education.

Combining these results with Assumptions 1–3, we then estimated the key components needed to identify SACE. The estimate of P[Y(1) = 1|D(1) = 0], the probability of emotional distress among survivors if everyone had been "assigned" vision loss, is 14.8% (95% CI: [8.6%, 24.2%]), higher than the (potentially) confounded estimate, from Table 2, of 12.4%. The estimate of P[Y(0) = 1|D(0) = 0], the corresponding probability of emotional distress if everyone had been "assigned" no vision loss, is 10.6% (95% CI: [9.0%, 12.3%]), which is slightly higher than the (potentially) confounded estimate of 10.4%. The estimated conditional probability of surviving with vision loss given that one would also survive without vision loss, P[D(1) = 0|D(0) = 0], is 93.5% (95% CI: [81.0%, 97.9%]). Plugging these estimates into (4.2) and assuming that P[Y(0) = 1|S1] ≤ P[Y(0) = 1|S2], we can see that the estimated values of P[Y(0) = 1|S1] must lie between 0.044 and 0.106 and P[Y(0) = 1|S2] must lie between 0.106 and 1. For fixed {tau}OR between 1 and 15 (with associated {tau}RR between 1 and 7.3), P[Y(0) = 1|S1] decreases from 0.106 to 0.075 and P[Y(0) = 1|S2] increases from 0.106 to 0.549. Hence, over this range of {tau}OR and {tau}RR, we are ranging over very broad discrepancies between P[Y(0) = 1|S1] and P[Y(0) = 1|S2].

Figure 3 presents the estimated values of SACE and associated confidence intervals over {tau}OR ranging from 1 to 15 and {tau}RR ranging from 1 to 7. We see that when the probability of emotional distress is the same regardless of whether an individual's potential outcomes indicate that an individual always lives or only lives without vision loss ({tau}OR = {tau}RR = 1), then the naive OR and SACE are similar. As {tau}OR and {tau}RR get larger, the probability of emotional distress given an individual always lives gets much smaller than the probability of emotional distress given that an individual only lives without vision loss. As a result, SACE gets larger. The slopes are very shallow because the estimated proportion of subjects in S2 is small. The unconditional {tau}RR and {tau}OR that correspond to CCI are both approximately 1.3 and 1.3, respectively. Under CCI, SACE = 1.50 (95% CI: [0.80, 2.82]).


Figure 3
View larger version (8K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 3. Estimates of SACE. (a) SACE under RR parameterization of {tau}. (b) SACE under OR parameterization of {tau}.

 

    7. DISCUSSION
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 
Our method of accounting for death as a competing risk provides a meaningful, readily interpretable, and easy to implement causal estimand. In our data analysis, we found that the point estimate of SACE was similar to that of the naive OR when there was no difference in the probability of worsening emotional distress symptoms between those who die only with vision loss versus those who never die whatever be their vision loss status. There were some changes in SACE over the specified range of {tau}OR and {tau}RR, but the results were only marginally significant. Further, the magnitude of the effect of vision loss on emotional distress seems modest in terms of clinical relevance except for large values of {tau}OR or {tau}RR.

SACE does not correct for bias of the naive OR; the two ORs are measuring different quantities. The naive OR measures the effect of vision loss on emotional distress among those who are observed to live. Under Assumption 1, some of those who we observed to survive without vision loss would have died with vision loss; our causal estimand excludes this group. For this reason, even when {tau}OR or {tau}RR equals 1, the interpretation of SACE and the naive OR are different and the point estimates can be expected to differ, as was the case in our analysis.

Our method can be applied to continuous outcomes by replacing P[Y(0) = 1|S1] and P[Y(1) = 1|S1] with E[Y(0)|S1] and E[Y(1)|S1] and examining the difference in the expectations. A few changes are necessary for implementation in the continuous case. First, a model is needed for hz(X) = E[Y|D = 0,Z = z,R = 1,X] instead of the logit model specified above. While {tau}OR is not applicable in the continuous case, one can still use E[Y(0)|S2]/E[Y(0)|S1] in place of Assumption 4a for identification. If the continuous variable is bounded, a restriction similar to that presented in (4.7) is necessary to ensure that E[Y(0)|S1] is within the appropriate bounds. One would also need to replace expit{hFormula(X;ßz)} with hFormula(X;ßz) in the estimating equations presented in Section 5.

One potential criticism of this work is that vision loss is not manipulable in the same manner as a randomized treatment. As Holland (1986)Go wrote, many have historically believed that Rubin's causal model is only applicable if one can conceptualize being able to manipulate the exposure. Under this conceptualization, immutable attributes such as sex are not considered causes. Changing the sex changes the person in too many ways to consider sex to be an underlying cause of anything. While vision loss may not be as manipulable as a randomized treatment, vision loss is an increasingly preventable and treatable condition; proper treatment can prevent vision loss due to glaucoma while laser-assisted in situ keratomileusis (LASIK) and cataract surgery can be used to reverse vision loss. As demonstrated by Freeman and others (2005)Go, vision researchers are interested in causal effects of vision loss.

The methods described here should be of use to many researchers who examine outcomes when death is a strong competing risk in observational studies. We are confident that scientists will increasingly use estimators of SACE in their substantive work once they become more familiar with the concept of principal stratification, and once computer programs to estimate SACE are made more widely available.


    ACKNOWLEDGMENTS
 
This research was supported by the National Institute on Aging, Grants T32 AG00247 and NIA AG10184. Conflict of Interest: None declared.


    REFERENCES
 TOP
 SUMMARY
 1. INTRODUCTION
 2. THE SEE
 3. DATA STRUCTURE AND...
 4. IDENTIFICATION OF SACE
 4.3 Models for gz(X)...
 5. ESTIMATION AND LARGE...
 6. DATA ANALYSIS
 7. DISCUSSION
 REFERENCES
 

    Avlund K, Lund R, Holstein BE, Due P, Sakari-Rantala R, Heikkinen RL. The impact of structural and functional characteristics of social relations as determinants of functional decline. Journal of Gerontology Series B: Social Sciences (2004) 59:S44–S51.

    Black SA, Markides KS. Depressive symptoms and mortality in older Mexican Americans. Annals of Epidemiology (1999) 9:45–52.[CrossRef][Web of Science][Medline]

    Blazer DG, Hybels CF, Pieper CF. The association of depression and mortality in elderly persons: a case for multiple, independent pathways. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences (2001) 56:M505–M509.

    Boerner K, Wortman CB, Bonanno GA. Resilient or at risk? A 4-year study of older adults who initially showed high or low distress following conjugal loss. Journal of Gerontology Series B: Psychological Sciences (2005) 60:P67–P73.

    Carabellese C, Appollonio I, Rozzini R, Bianchetti A, Frisoni GB, Frattola L, Trabucchi M. Sensory impairment and quality of life in a community elderly population. Journal of the American Geriatrics Society (1993) 41:401–407.[Web of Science][Medline]

    Chen PC, Wilmoth JM. The effects of residential mobility on ADL and IADL limitations among the very old living in the community. Journal of Gerontology Series B: Social Sciences (2004) 59:S164–S172.

    Ferraro KF, Kelley-Moore JA. A half century of longitudinal methods in social gerontology: evidence of change in the journal. Journal of Gerontology Series B: Social Sciences (2003) 58:S264–S270.

    Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics (2002) 58:21–29.[CrossRef][Web of Science][Medline]

    Freeman EE, Egleston BL, West SK, Bandeen-Roche K, Rubin G. Visual acuity changes and mortality in older adults. Investigative Ophthalmology and Visual Science (2005) 46:4040–4045.[Abstract/Free Full Text]

    Gilbert PB, Bosch RJ, Hudgens MG. Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials. Biometrics (2003) 59:531–541.[CrossRef][Web of Science][Medline]

    Gilley DW, Wilson RS, Bienias JL, Bennett DA, Evans DA. Predictors of depressive symptoms in persons with Alzheimer's disease. Journal of Gerontology Series B: Psychological Sciences (2004) 59:P75–P83.

    Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychological Medicine (1979) 9:139–145.[Web of Science][Medline]

    Hayden D, Pauler DK, Schoenfeld D. An estimator for treatment comparisons among survivors in randomized trials. Biometrics (2005) 61:305–310.[CrossRef][Web of Science][Medline]

    Holland PW. Statistics and causal inference. Journal of the American Statistical Association (1986) 81:945–960.[CrossRef][Web of Science]

    Huber PJ. Robust estimation of a location parameter. The Annals of Mathematical Statistics (1964) 35:73–101.[CrossRef]

    Hudgens MG, Hoering A, Self SG. On the analysis of viral load endpoints in HIV vaccine trials. Statistics in Medicine (2003) 22:2281–2298.[CrossRef][Web of Science][Medline]

    Jorm AF, Henderson AS, Scott R, Korten AE, Christensen H, Mackinnon AJ. Factors associated with the wish to die in elderly people. Age and Ageing (1995) 24:389–392.[Abstract/Free Full Text]

    Klein R, Klein BE, Moss SE. Age-related eye disease and survival. The Beaver Dam Eye Study. Archives of Ophthalmology (1995) 113:333–339.[Abstract/Free Full Text]

    McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5-year mortality. The British Journal of Ophthalmology (2001) 85:322–326.[Abstract/Free Full Text]

    Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, Bandeen-Roche K. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Archives of Ophthalmology (2000) 118:819–825.[Abstract/Free Full Text]

    Neyman J. On the application of probability theory to agricultural experiments. essay on principles. In: Statistical Science (1923) 5:465–472. [As translated and edited by D.M. Dabrowska and T.P. Speed from the original in Roczniki Nauk Rolniczych Tom X 1-51, 1990].

    Robins JM. An analytic method for randomized trials with informative censoring: part 1. Lifetime Data Analysis (1995) 1:241–254.[CrossRef][Medline]

    Robins JM, Greenland S. Comment to causal inference without counterfactuals. Journal of the American Statistical Association (2000) 95:431–435.[CrossRef][Web of Science]

    Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika (1983) 70:41–55.[Abstract/Free Full Text]

    Rovner B, Ganguli M. Depression and disability associated with impaired vision: the MoVIES Project. Journal of the American Geriatrics Society (1998) 46:617–619.[Web of Science][Medline]

    Rovner BW, Zisselman PM, Shmuely-Dulitzki Y. Depression and disability in older people with impaired vision: a follow-up study. Journal of the American Geriatrics Society (1996) 44:181–184.[Web of Science][Medline]

    Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology (1974) 66:688–701.[CrossRef][Web of Science]

    Rubin DB. Inference and missing data. Biometrika (1976) 63:581–592.[Abstract/Free Full Text]

    Rubin DB. Comment on randomization analysis of experimental data: the Fisher randomization test, by D. Basu. Journal of the American Statistical Association (1980) 75:591–593.[CrossRef][Web of Science]

    Rubin DB. Comment to causal inference without counterfactuals. Journal of the American Statistical Association (2000) 95:435–438.[CrossRef][Web of Science]

    Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Archives of Internal Medicine (2000) 160:1761–1768.[Abstract/Free Full Text]

    Scott IU, Schein OD, Feuer WJ, Folstein MF, Bandeen-Roche K. Emotional distress in patients with retinal disease. American Journal of Ophthalmology (2001) 131:584–589.[CrossRef][Web of Science][Medline]

    Stern SL, Dhanda R, Hazuda HP. Hopelessness predicts mortality in older Mexican and European Americans. Psychosomatic Medicine (2001) 63:344–351.[Abstract/Free Full Text]

    Steunenberg B, Twisk JWR, Beekman ATF, Deeg DJH, Kerkhof AJFM. Stability and change of neuroticsm in aging. Journal of Gerontology Series B: Psychological Sciences (2005) 60:P27–P33.

    Thompson JR, Gibson JM, Jagger C. The association between visual impairment and mortality in elderly people. Age and Ageing (1989) 18:83–88.[Abstract/Free Full Text]

    van Hooren SAH, Valentijn SAM, Bosma H, Ponds RWHM, van Boxtel MPJ, Jolles J. Relation between health status and cognitive functioning: a 6-year follow-up of the Maastricht Aging Study. Journal of Gerontology Series B: Psychological Sciences (2005) 60:P57–P60.

    West SK, Munoz B, Rubin GS, Schein OD, Bandeen-Roche K, Zeger S, German S, Fried LP. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Investigative Ophthalmology and Visual Science (1997) 38:72–82.[Abstract/Free Full Text]

    Zhang JL, Rubin DB. Estimation of causal effects via principal stratification when some outcomes are truncated by "death. Journal of Educational and Behavioral Statistics (2003) 28:353–368.[Abstract/Free Full Text]

    Received June 27, 2005; revised March 8, 2006; revised August 2, 2006; revised September 1, 2006; accepted for publication September 13, 2006.


    Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


    This article has been cited by other articles:


    Home page
    Eval RevHome page
    S. McConnell, E. A. Stuart, and B. Devaney
    The Truncation-by-Death Problem: What To Do in an Experimental Evaluation When the Outcome Is Not Always Defined
    Eval Rev, April 1, 2008; 32(2): 157 - 186.
    [Abstract] [PDF]


    Home page
    JBJSHome page
    E. J. MacKenzie, F. P. Rivara, G. J. Jurkovich, A. B. Nathens, B. L. Egleston, D. S. Salkever, K. P. Frey, and D. O. Scharfstein
    The Impact of Trauma-Center Care on Functional Outcomes Following Major Lower-Limb Trauma
    J. Bone Joint Surg. Am., January 1, 2008; 90(1): 101 - 109.
    [Abstract] [Full Text] [PDF]


    This Article
    Right arrow Abstract Freely available
    Right arrow FREE Full Text (PDF) Freely available
    Right arrow All Versions of this Article:
    8/3/526    most recent
    kxl027v1
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Add to My Personal Archive
    Right arrow Download to citation manager
    Right arrowRequest Permissions
    Right arrow Disclaimer
    Google Scholar
    Right arrow Articles by Egleston, B. L.
    Right arrow Articles by West, S. K.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Egleston, B. L.
    Right arrow Articles by West, S. K.
    Social Bookmarking
     Add to CiteULike   Add to Connotea   Add to Del.icio.us  
    What's this?